Joana C M Narvaez1, Karen Jansen2, Ricardo T Pinheiro2, Flávio Kapczinski3, Ricardo A Silva2, Flávio Pechansky4, Pedro V Magalhães5. 1. National Institute for Translational Medicine, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; Center for Drug and Alcohol Research, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. 2. Graduate Program in Health and Behavior, Universidade Católica de Pelotas, Pelotas, Brazil. 3. National Institute for Translational Medicine, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. 4. Center for Drug and Alcohol Research, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. 5. National Institute for Translational Medicine, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. Electronic address: pedromaga2@gmail.com.
Abstract
OBJECTIVE: To assess the association between lifetime crack cocaine use and psychiatric (post-traumatic stress disorder, current depression, current dysthymia, generalized anxiety disorder, panic disorder with agoraphobia, social phobia, as well as SRQ scores and suicide risk) and substance-use disorders (tobacco, alcohol, cannabis, cocaine, amphetamine, inhalants, sedatives, hallucinogens and opioids) in youth in the general population of the city of Pelotas, RS. METHOD: This was a cross-sectional population-based study, involving 1560 participants between 18 and 24 ears old. Lifetime substance use and abuse were investigated using the ASSIST inventory. Psychiatric comorbidities were assessed using the Mini-International Neuropsychiatric Interview and symptoms of common mental disorders were evaluated with the Self-Reported Questionnaire (SRQ). RESULTS: The prevalence of lifetime crack cocaine use in the sample was 2.5%. Its use was associated with total SRW scores and the presence of post-traumatic stress disorder, antisocial personality disorder and suicide risk in the final regression model. Tobacco, alcohol, cannabis, cocaine, amphetamine and cocaine dependence were also associated with lifetime use of crack cocaine. DISCUSSION: Youth with a history of crack cocaine use had a higher prevalence of psychiatric conditions such as post-traumatic stress disorder, as well as an increased risk of tobacco, alcohol, cannabis, cocaine, amphetamine and inhalant use and dependence.
OBJECTIVE: To assess the association between lifetime crack cocaine use and psychiatric (post-traumatic stress disorder, current depression, current dysthymia, generalized anxiety disorder, panic disorder with agoraphobia, social phobia, as well as SRQ scores and suicide risk) and substance-use disorders (tobacco, alcohol, cannabis, cocaine, amphetamine, inhalants, sedatives, hallucinogens and opioids) in youth in the general population of the city of Pelotas, RS. METHOD: This was a cross-sectional population-based study, involving 1560 participants between 18 and 24 ears old. Lifetime substance use and abuse were investigated using the ASSIST inventory. Psychiatric comorbidities were assessed using the Mini-International Neuropsychiatric Interview and symptoms of common mental disorders were evaluated with the Self-Reported Questionnaire (SRQ). RESULTS: The prevalence of lifetime crack cocaine use in the sample was 2.5%. Its use was associated with total SRW scores and the presence of post-traumatic stress disorder, antisocial personality disorder and suicide risk in the final regression model. Tobacco, alcohol, cannabis, cocaine, amphetamine and cocaine dependence were also associated with lifetime use of crack cocaine. DISCUSSION: Youth with a history of crack cocaine use had a higher prevalence of psychiatric conditions such as post-traumatic stress disorder, as well as an increased risk of tobacco, alcohol, cannabis, cocaine, amphetamine and inhalant use and dependence.
Authors: Nathan A Gillespie; Steven H Aggen; Amanda E Gentry; Michael C Neale; Gun P Knudsen; Robert F Krueger; Susan C South; Nikolai Czajkowski; Ragnar Nesvåg; Eivind Ystrom; Tom H Rosenström; Fartein A Torvik; Ted Reichborn-Kjennerud; Kenneth S Kendler Journal: Twin Res Hum Genet Date: 2018-02 Impact factor: 1.587
Authors: Mayara Sabrina A Rodrigues; Raquel Silva Nascimento; Ricardo Roberto S Fonseca; Gláucia C Silva-Oliveira; Luiz Fernando A Machado; Emil Kupek; Benedikt Fischer; Aldemir B Oliveira-Filho Journal: Clin Oral Investig Date: 2020-11-22 Impact factor: 3.573
Authors: André Q C Miguel; Clarice S Madruga; Hugo Cogo-Moreira; Rodolfo Yamauchi; Viviane Simões; Ariadne Ribeiro; Claudio J da Silva; Andrew Fruci; Michael McDonell; Sterling McPherson; John M Roll; Ronaldo R Laranjeira Journal: Exp Clin Psychopharmacol Date: 2017-12 Impact factor: 3.157
Authors: Simon Zhornitsky; Thang M Le; Isha Dhingra; Brendan D Adkinson; Stephane Potvin; Chiang-Shan R Li Journal: Suicide Life Threat Behav Date: 2020-02-06
Authors: André Q C Miguel; Clarice S Madruga; Hugo Cogo-Moreira; Rodolfo Yamauchi; Viviane Simões; Claudio J Da Silva; Renata R Abdalla; Michael McDonell; Sterling McPherson; John M Roll; Jair J Mari; Ronaldo R Laranjeira Journal: J Psychoactive Drugs Date: 2018-03-12
Authors: Patricia Ramos Cury; Nara Santos Araujo; Maria das Graças Alonso Oliveira; Jean Nunes Dos Santos Journal: Environ Sci Pollut Res Int Date: 2018-05-08 Impact factor: 4.223
Authors: André Q C Miguel; Clarice S Madruga; Hugo Cogo-Moreira; Rodolfo Yamauchi; Viviane Simões; Claudio J da Silva; Sterling McPherson; John M Roll; Ronaldo R Laranjeira Journal: Psychol Addict Behav Date: 2016-07-21